Using Ecstacy for Treatment of PTSD
In recent years, reseach within the psychiatric community has highlighted the benefits of using Ecstacy for treatment of post-traumatic stress disorder (PTSD). The first randomized trial highlighting the benefits of MDMA (the active ingrident in Ecstacy) was published by Michael Mithoefer, Mark Wagner, Ann Mithoefer, Lisa Jerome, and Rick Doblin. Their study showed that individuals suffering from treatment-resistant PTSD (PTSD that had not responded to therapy or medication interventions) showed a robust response in decrease of symptoms after only two treatment sessions. No significant emotional, mental, or physical side effects were observed. If you would like to read more about this study, please click on the document below to download the origional study.
This is groundbreaking research in PTSD treatment. PTSD has gained recent media attention as a disorder commonly seen among combat vetrans. While this is true, PTSD also affects civilians who have experienced trauma (abuse, natural disasters, witnesses to a crime). The way the mind reacts to a trauma is unique to each individual - two peiople can witness the same event and only one might develop PTSD. The difference is between these two individuals amounts to a complex layer of genetics and environmental influences that have shaped the brain over many years. PTSD if a very real disorder where individuals re-experience elements of prior trauma. This "re-experiencing" can come in the form of a flood of emotions, recollection of memories, or sights/sounds. If you would like to learn more about PTSD, please visit the website below. There are other resources that can be found through a simple Google search.